Entity Details

Primary name PMM2
Entity type gene
Source Source Link

Details

PrimaryID5373
RefseqGeneNG_009209
SymbolPMM2
Namephosphomannomutase 2
Chromosome16
Location16p13.2
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1998-08-24
ModificationDate2021-06-20

Ontological Relatives

UniProt IDsPMM2_HUMAN

GO terms

Show/Hide Table
GOName
GO:0004615 phosphomannomutase activity
GO:0005654 nucleoplasm
GO:0005829 cytosol
GO:0006013 mannose metabolic process
GO:0006486 protein glycosylation
GO:0006487 protein N-linked glycosylation
GO:0009298 GDP-mannose biosynthetic process
GO:0043025 neuronal cell body
GO:0046872 metal ion binding

Diseases

Show/Hide Table
Disease IDSourceNameDescription
212065 OMIMCongenital disorder of glycosylation 1A (CDG1A)A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. CDG1A is an autosomal recessive disorder characterized by a severe encephalopathy with axial hypotonia, abnormal eye movement, and pronounced psychomotor retardation, as well as peripheral neuropathy, cerebellar hypoplasia, and retinitis pigmentosa. Patients show a peculiar distribution of subcutaneous fat, nipple retraction, and hypogonadism. The disease is caused by variants affecting the gene represented in this entry.